Archived 33: Summary of NACI statement of February 17, 2022: Recommendations on the use of Novavax Nuvaxovid COVID-19 vaccine

ASEM documentary overview

Official National Advisory Committee on Immunization document (2022) on “Archived 33: Summary of NACI statement of February 17, 2022: Recommendations on the use of Novavax Nuvaxovid COVID-19 vaccine”. What you need to know: NACI summary of recommendations for use of the recombinant protein subunit COVID-19 vaccine Novavax Nuvaxovid.

This overview helps you identify the document. Always consult the current official publication for clinical recommendations.